<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>5926</number>
    <updateDate>2023-01-11T13:39:27Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:39:27Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2018-05-23</introducedDate>
    <congress>115</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 164, Number 85 (Wednesday, May 23, 2018)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. KEATING:H.R. 5926.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the United States Constitution.By Mr. SOTOH.R. 5927.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, of the United States Constitution.By Mr. POLISH.R. 5928.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 of the U.S. Constitution[Page H4693]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2018-05-23T14:02:40Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>SUPPORT for Patients and Communities Act</title>
        <congress>115</congress>
        <number>6</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2018-10-24</actionDate>
          <text>Became Public Law No: 115-271.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2018-05-23</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2018-05-23</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2018-05-23</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>K000375</bioguideId>
        <fullName>Rep. Keating, William R. [D-MA-9]</fullName>
        <firstName>William</firstName>
        <lastName>Keating</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>R.</middleName>
        <district>9</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>R000598</bioguideId>
        <fullName>Rep. Rothfus, Keith J. [R-PA-12]</fullName>
        <firstName>Keith</firstName>
        <lastName>Rothfus</lastName>
        <party>R</party>
        <state>PA</state>
        <middleName>J.</middleName>
        <district>12</district>
        <sponsorshipDate>2018-05-23</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Drug therapy</name>
        </item>
        <item>
          <name>Drug, alcohol, tobacco use</name>
        </item>
        <item>
          <name>Health promotion and preventive care</name>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2018-05-23</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2019-03-19T22:50:07Z</updateDate>
        <text><![CDATA[ <p><b>Naloxone Guidelines Act of 2018</b></p> <p>This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone). </p> <p>The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including: </p> <ul> <li> co-prescription with an opioid;</li> <li>safe dosages;</li> <li> prescription for non-patients; and</li> <li>standing orders (i.e., orders that allow dispensing without a prescription).</li></ul>]]></text>
      </summary>
    </summaries>
    <title>Naloxone Guidelines Act of 2018</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Naloxone Guidelines Act of 2018</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Naloxone Guidelines Act of 2018</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2018-05-23T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr5926ih/xml/BILLS-115hr5926ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2018-05-23</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
